. 2014 Mar 14;3(3):e13. doi: 10.1038/cti.2014.4

Table 1. Leishmania vaccine antigens being tested as candidate DNA vaccines.

Candidate antigen	Models	Disease	Species	Reference
LACK	Dog, mice	VL, CL	L. donovani, L. chagasi, L. major, L. infantum	^{86, 87, 88, 89, 90}
gp63	Mice, dogs	CL, VL	L. major, L. infantum	^{88, 90}
KMP11	Mice	CL, VL	L. major L. donovani	^{91, 92, 93}
CPB	Dogs, mice	VL, CL	L. infantum, L. major	^{94, 95}
ORFF	Mice	VL	L. donovani	⁹⁶
NH 36	Mice	VL, CL	L. chagasi, L. maxicana	^{97, 98}
TRYP	Dogs	VL	L. infantum	⁹⁰
PSA-2	Mice	CL	L. major	⁸⁸

Abbreviations: CPB, cysteine proteinase B; CL, cutaneous leishmaniasis; gp63, glycoprotein 63; KMP11, kinetoplastid membrane protein-11; LACK, Leishmania-activated C kinase; NH36, nucleoside hydrolase 36; ORFF, open reading frame F; PSA-2, promastigote surface antigen 2; TRYP, tryparedoxin peroxidase; VL, visceral leishmaniasis.